Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hunterase in Hunter syndrome extension study
NCT07344376Phase 3Completed
- Sponsor
- GC Biopharma Corp
- Start
- May 2018
- Primary completion
- Dec 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Idursulfase beta in mucopolysaccharidosis type II, sponsored by GC Biopharma Corp. Started May 2018; status: completed.
02
Drugs
Idursulfase beta
03
Conditions
mucopolysaccharidosis type II
Beyond the preview
Go deeper on NCT07344376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07344376.